MEDVi vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats WeightWatchers (Sequence) overall, scoring 7.7/10 vs 7.4/10. WeightWatchers (Sequence) is more affordable at $74/mo vs $179/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.
A side-by-side look at MEDVi and WeightWatchers (Sequence) to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MEDVi
#20 of 52MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.
Visit MEDViWeightWatchers (Sequence)
#28 of 52WeightWatchers' clinical weight management arm (acquired from Sequence). Membership is tiered: 12-month plan first month $149-$299 depending on tier, then $74/mo ongoing for months 2-12; shorter plans are higher per-month. Medication billed separately: $199/mo intro for 2 months, then $349/mo ongoing. Lineup includes Saxenda (liraglutide brand), Wegovy, Zepbound, and compounded semaglutide/tirzepatide.
Visit WeightWatchers (Sequence)| Feature | MEDVi | WeightWatchers (Sequence) |
|---|---|---|
| Our Score | 7.7/10 | 7.4/10 |
| Starting Price | $179/mo | $74/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Users who want a low entry price with oral and injectable compounded options | Users who want GLP-1 medication combined with the WeightWatchers program and community, on the $74/mo MED+ membership ($20/mo for the first 3 months), with GLP-1 meds billed separately |
| Ranking | #20 | #28 |
| Get started | Visit MEDVi | Visit WeightWatchers (Sequence) |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag
WeightWatchers (Sequence)
Pros
- +Combines GLP-1 medication with WeightWatchers' proven points system and community support
- +Insurance accepted for medication, can reduce costs significantly with qualifying plans
- +Decades of brand trust and weight loss expertise applied to clinical medication management
- +Access to WW community, workshops, and digital tools alongside medication
Cons
- −$269/mo without insurance is expensive for what's included clinically
- −The WW program integration adds complexity that medication-only users won't value
- −The Sequence acquisition is still integrating, some operational inconsistencies remain
- −Less medication flexibility than pure-play GLP-1 platforms
Our Verdict
MEDVi edges out WeightWatchers (Sequence) with a score of 7.7/10 vs 7.4/10. If budget is your priority, WeightWatchers (Sequence) starts at $74/mo compared to MEDVi's $179/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community, on the $74/mo med+ membership ($20/mo for the first 3 months), with glp-1 meds billed separately.
Still undecided? Editor's Featured Pick
Yucca Health
$146/mo · 7.7/10 · Compounded
If neither MEDVi nor WeightWatchers (Sequence) feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing MEDVi or WeightWatchers (Sequence) tend to look at next.
- MEDVi vs Shed$199/mo
- MEDVi vs Hers$199/mo
- MEDVi vs Henry Meds$199/mo
- WeightWatchers (Sequence) vs Noom Med$99/mo
- WeightWatchers (Sequence) vs Sprout Health$199/mo
- WeightWatchers (Sequence) vs Enhance MD$212/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.